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From January 2014 to December 2014, 972 con-
secutive non-replicate carbapenemase-produc-
ing Enterobacteriaceae isolates from colonised or 
infected patients were collected at the Associated 
French National Reference Centre as part of the 
French national survey on antimicrobial resistance. It 
included 577 Klebsiella spp. (59%), 236 Escherichia 
coli (24%), 108 Enterobacter spp. (11%), 50 Citrobacter 
spp. (5%), and a single Salmonella spp. isolate (0.1%). 
Of 561 K. pneumoniae isolates, 35 were found to be 
resistant to colistin (6.2%). PFGE analysis revealed a 
clonal outbreak involving 15 K. pneumoniae isolates 
belonging to sequence type ST11, recovered in a sin-
gle hospital in the Picardie region in northern France. 
Those clonally related isolates showed variable levels 
of resistance to colistin, ranging from 4 to 64 mg/L. 
They harboured the blaOXA-48 carbapenemase gene 
and the blaCTX-M-15 extended-spectrum beta-lactamase 
gene. Among the 91 Enterobacter cloacae isolates, 
seven were resistant to colistin and produced different 
types of carbapenemases. Surprisingly, none of the E. 
coli and Citrobacter spp. isolates showed resistance 
to colistin. This national survey including carbapene-
mase-producing isolates recovered in 2014 reported a 
high rate of colistin resistance in K. pneumoniae and 
E. cloacae (6.2% and 7.7%, respectively) in France.
Introduction
Carbapenemase-producing Enterobacteriaceae (CPE) 
resistant to colistin are increasingly reported. They 
represent an additional link in the development of 
pan-drug resistance. However, the epidemiology of 
colistin resistance among enterobacterial isolates is 
currently almost unknown in most parts of the world. 
In Italy, an increase in carbapenemase-producing 
Enterobacteriaceae has been noted in the past years, 
but the situation remains unknown in France [1]. The 
lack of information about the prevalence of colistin 
resistance among multidrug-resistant enterobacterial 
isolates derives from several reasons: (i) so far, there 
has been limited interest in that field, (ii) methods 
used for determination of colistin susceptibility are not 
adequate, and (iii) the lack of well-defined breakpoints 
does not allow precise determination of prevalence. 
However, the recent identification of a plasmid-borne 
polymyxin resistance determinant (MCR-1) raised a 
very serious concern in that resistance to colistin might 
widely disseminate [2].
The aim of this study was to evaluate retrospectively 
the prevalence of colistin resistance among a collec-
tion of CPE strains recovered in France during a period 
of one year and to analyse the phenotypic, genotypic 
features and clonality of the colistin-resistant isolates.
Methods
Carbapenemase-producing Enterobacteriaceae 
isolates
From January to December 2014, 972 consecutive 
non-duplicate isolates of carbapenemase-producing 
Enterobacteriaceae were isolated in private laborato-
ries and hospitals in France either by screening for colo-
nisation or by analysing clinical samples in the context 
of infections. They were recovered from rectal swabs 
or stools (n = 625), urine samples (n = 250), respiratory 
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tract samples (n = 35), blood samples (n = 22), wounds 
(n = 24), catheter (n = 7), vaginal swabs (n = 3) and other 
specimens (n = 6). Those isolates were sent to the 
Associated French National Reference Centre for char-
acterisation of resistance mechanisms to carbapenems 
as part of the French antibiotic resistance survey. The 
972 carbapenemase-producing Enterobacteriaceae iso-
lates included 577 isolates of Klebsiella spp. (59%), 
236 isolates of Escherichia coli (24%), 108 isolates 
of Enterobacter spp. (11%), 50 isolates of Citrobacter 
spp. (5%), and a single isolate of Salmonella spp. 
(0.1%). Species that are naturally resistant to colistin 
(Proteus spp., Morganella morganii, Providencia spp., 
and Serratia spp.) had been excluded before the initia-
tion of this study. Only a single isolate per patient was 
included in the study. All isolates were identified using 
the Microflex bench-top MALDI-TOF mass spectrometer 
(Bruker, Champs-sur-Marne, France).
Antimicrobial susceptibility testing
Minimum inhibitory concentrations (MIC) of colistin 
(CS) were determined using broth microdilution method 
according to the guidelines of the Clinical Laboratory 
Standards Institute (CLSI) [3]. As recommended, E. coli 
ATCC 25922 was used as quality control strain.
For the colistin-resistant isolates, susceptibil-
ity to other classes of antibiotics was also tested. 
Susceptibility to imipenem, ertapenem, and tigecycline 
was tested by broth microdilution method according to 
CLSI guidelines, whereas susceptibility to the other 
antibiotics was tested by the standardised agar disk 
diffusion method according to the guidelines of the 
European Committee on Antimicrobial Susceptibility 
Testing (EUCAST) [4]. The antibiotics tested using disk 
diffusion method were: amoxicillin (AMX), amoxicil-
lin/clavulanic acid (AMC), cefotaxime (CTX), cefoxitin 
(FOX), ceftazidime (CAZ), cefepime (FEP), temocillin 
(TEM), ciprofloxacin (CIP), gentamicin (GM), amikacin 
Figure 1
Geographic distribution of colistin-resistant Enterobacteriaceae isolates, France, January–December 2014 (n = 43)
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(AK), trimethoprim-sulfamethoxazole (SXT) and fosfo-
mycin (FOS).
The MIC results for colistin and the disk diffusion 
diameters were interpreted according to suscepti-
bility breakpoints of the European Committee on 
Antimicrobial Susceptibility Testing (EUCAST) [4].
Molecular characterisation
The mgrB genes of K. pneumoniae and Enterobacter 
spp. isolates were amplified using specific primers 
(Table 1), knowing that the MgrB protein is a nega-
tive regulator of the PhoPQ two-component system 
and that alterations in the mgrB gene are commonly 
involved in acquisition of colistin resistance in K. 
pneumoniae [5-7]. The plasmid-mediated mcr-1 gene 
encoding colistin resistance was sought as described 
previously [2]. Detection of extended-spectrum beta-
lactamases (ESBL) and carbapenemases genes was 
performed with specific primers as described previ-
ously [8]. Both strands of the amplification products 
obtained were sequenced with an ABI 3100 sequencer 
(Applied Biosystems, Foster City, US). The nucleotide 
and deduced protein sequences were analysed at the 
National Centre for Biotechnology Information website 
(www.ncbi.nlm.nih.gov) by the Basic Local Alignment 
Search Tool (BLAST) programme.
Genotyping
Genotyping was performed to evaluate the clonal rela-
tionship of the colistin-resistant K. pneumoniae and 
E. cloacae isolates by pulsed-field gel elctrophoresis 
(PFGE) with XbaI-digested genomic DNA and interpreted 
according to Tenover criteria [9]. Multilocus sequence 
typing (MLST) for K. pneumoniae was performed using 
the simplified protocol at the Institut Pasteur website 
(http://bigsdb.pasteur.fr/klebsiella/klebsiella.html) 
[10].
Results
Klebsiella pneumoniae 
Of 561 K. pneumoniae isolates, 35 were found to be 
resistant to colistin (6%). Fifteen of the 35 colistin-
resistant K. pneumoniae isolates were recovered from 
a single hospital in the Picardie region, northern France 
(Figure 1). We could not obtain the exact dates of their 
isolations due to the retrospective nature of the study. 
These isolates had mostly been recovered from rectal 
swab specimens, but also from a catheter, a urinary 
sample, a wound exudate and a respiratory specimen 
(isolates 1 to 15, Table 2). PFGE analysis revealed that 
the 15 isolates were clonally related (Figure 2, Table 2). 
The clone was of the ST11 type, and was susceptible 
only to cefoxitin, amikacin and fosfomycin (Table 2). A 
single isolate among these 15 was susceptible to tige-
cycline. The 15 isolates harboured both the blaOXA-48 
carbapenemase gene, and the blaCTX-M-15 extended-
spectrum beta-lactamase (ESBL) gene, and the MICs 
for colistin ranged from 4 to 64 mg/L (Table 2).
The other 20 colistin-resistant K. pneumoniae strains 
were mostly recovered from the regions Ile-de-France 
(n = 6) and Provence-Alpes-Côte d’Azur (n = 10) (Figure 
1). These strains presented high MIC values for colistin 
ranging from 16 to >128 mg/L (isolates 16 to 35, Table 
2). They produced either the carbapenemases OXA-48 
(15/20), KPC-2 (3/20), NDM-1 (1/20), or both OXA-48 
and NDM-1 together (1/20) (Table 2). Overall, 14 of the 
20 isolates produced the ESBL CTX-M-15. PFGE analy-
sis identified 18 clonal patterns among the 20 iso-
lates (n = 3 for clone M) (Figure 2, Table 2), and MLST 
assigned the isolates to eight sequence types (STs) 
(Table 2).
Sequencing of the mgrB gene of those K. pneumoniae 
isolates revealed various mgrB alterations and none 
Figure 2
PFGE patterns of XbaI-digested chromosomal DNA of colistin-resistant Klebsiella pneumoniae isolates, France, January–
December 2014 (n = 35)
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The numbers correspond to the isolates from Table 2 and the letters indicate the PFGE type.
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of the strains harboured the plasmid-encoded mcr-1 
gene.
Antimicrobial susceptibility data for the colistin-resist-
ant K. pneumoniae isolates not involved in the outbreak 
revealed that most isolates (19/20) were non-suscep-
tible to third- and fourth-generation cephalosporins 
(Figure 3A). They were also frequently resistant to 
ciprofloxacin (19/20), trimethoprim-sulfamethoxazole 
(15/20) and tigecycline (14/20). They were less often 
resistant to gentamicin and cefoxitin (13/20 and 11/20, 
respectively). Amikacin and fosfomycin remained the 
most active agents against colistin-resistant K. pneu-
moniae (16/20 and 15/20 were susceptible, respec-
tively) (Figure 3A).
Enterobacter spp.
Among the 91 Enterobacter cloacae isolates, seven 
were resistant to colistin (7.7%). They showed high MIC 
values for colistin (ranging from 16 to >128 mg/L) (iso-
lates 36 to 42, Table 2). They produced the carbapen-
emases OXA-48 (4/7), VIM-1 (1/7), IMP-1 (1/7), or both 
OXA-48 and VIM-1 together (1/7) (Table 2). In total, 
three of seven strains were CTX-M producers, with two 
isolates producing CTX-M-15 and a single isolate pro-
ducing CTX-M-2. The colistin-resistant E. cloacae iso-
lates were recovered in different geographical regions 
in France (Figure 1, Table 2), and results of the PFGE 
analysis revealed that they were not clonally related 
(data not shown).
The single carbapenem-resistant E. asburiae strain 
was resistant to colistin. It had an MIC of colistin above 
128 mg/L and produced the VIM-1 carbapenemase (iso-
late 43, Table 2).
Figure 3
Antimicrobial non-susceptibilities among colistin-resistant isolates, France, January–December 2014
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All Enterobacter spp. isolates had a wild-type mgrB 
gene, leaving unexplained the colistin resistance 
mechanism (E. cloacae and E. asburiae) (Table 2).
Of the eight colistin-resistant Enterobacter spp. iso-
lates, four were non-susceptible to cefepime and 
tigecycline, and three were non-susceptible to cip-
rofloxacin, trimethoprim-sulfamethoxazole and gen-
tamicin (Figure 3B). Amikacin and fosfomycin were the 
most active agents against colistin-resistant E. cloacae 
(all seven isolates were susceptible) (Figure 3B).
Other species
None of the E. coli (n = 236) and Citrobacter spp. (n = 50) 
isolates were resistant to colistin.
Discussion
We describe here a clonal outbreak involving 15 K. 
pneumoniae isolates recovered from a single hospital 
in the Picardie region in northern France. This outbreak 
was caused by a colistin-resistant OXA-48 and CTX-
M-15-producing K. pneumoniae of ST11 type that was 
susceptible only to cefoxitin, amikacin and fosfomycin. 
Surprisingly, those clonally related isolates had vari-
able MIC values for colistin ranging from 4 to 64 mg/L. 
An ST11 clone co-producing OXA-48 and CTX-M-15 was 
responsible for a large outbreak involving 44 patients 
in a hospital in Madrid, Spain, from 2009 to 2014 but 
only 3.4% of the isolates were resistant to colistin [11].
Several outbreaks of colistin-resistant KPC-producing 
K. pneumoniae (mainly attributed to the international 
epidemic clone type ST258) have been reported across 
Europe, in Greece [12,13], Hungary [14], Italy [15-17] 
and the Netherlands [18]. A single outbreak of colis-
tin-resistant VIM-1-producing K. pneumoniae has also 
been described in Spain [19]. 
We report also 20 colistin-resistant K. pneumoniae 
strains recovered from the regions Ile-de-France and 
Provence-Alpes-Côte d’Azur. These strains belonged 
to 10 sequence types (n = 2 ST147, n = 3 ST258, n = 6 
ST101, n = 3 ST307) and PFGE analysis identified 18 pat-
terns among the 20 isolates. All three KPC-producing 
K. pneumoniae isolates belonged to ST258, the most 
common clone for KPC-producing isolates [20]. The 
OXA-48-producing K. pneumoniae isolates belonged to 
nine sequence types with six strains that were ST101, 
the most common clone identified among OXA-48-
positive K. pneumoniae [21].
Sequencing of the mgrB gene revealed mgrB altera-
tions which are likely to be responsible for colistin 
resistance as described previously [5-7]. Interestingly, 
the three strains belonging to the single clone M recov-
ered in the Provence-Alpes Côtes-d’Azur region had 
different mechanisms of mgrB inactivation (Table 2). 
The occurrence of such different mechanisms of colis-
tin resistance among clonally related isolates indicates 
that it is not the product of clonal dissemination of a 
single colistin-resistant K. pneumoniae strain, but 
rather clonal dissemination of a carbapenemase-pro-
ducing isolate, which has acquired colistin resistance 
thereafter.
The rates of colistin resistance among the carbapen-
emase-producing isolates were 7.7% for Enterobacter 
spp. and 3.6% for K. pneumoniae isolates (exclud-
ing the isolates responsible for the outbreak in the 
Picardie region). The resistance rate observed among 
the carbapenemase-producing K. pneumoniae isolates 
was much lower than the high rates reported in the 
neighbouring countries of southern Europe such as 
Spain (20%) [19] and Italy (43%) [1].
None of the 236 carbapenemase-producing E. coli iso-
lates were colistin-resistant or carried the mcr-1 gene. 
This is surprising considering that a recent report of the 
French antimicrobial resistance Resapath surveillance 
network identified the plasmid-borne mcr-1 gene in 
21% of ESBL-producing E. coli isolates recovered from 
faeces of veal calves in France between 2005 and mid-
2014 [22]. The plasmid-borne mcr-1 colistin resistance 
gene has also been found in many neighbouring coun-
tries of France, for example among ESBL-producing 
Enterobacteriaceae isolates recovered from river water 
and imported vegetable samples in Switzerland [23], 
in E. coli isolates recovered from calves and piglets in 
Belgium [24], in swine and human wound infections 
in Germany [25], and in food and human bloodstream 
infections in Denmark [26]. The mcr-1 gene was also 
detected in Salmonella enterica from food samples 
in Portugal [27] and France [28]. An E. coli isolate co-
harbouring the blaVIM-1 carbapenemase gene and the 
mcr-1 gene was described in Switzerland [29] and an 
isolate co-producing NDM-9 and MCR-1 was reported 
from China [30]. We believe that the plasmid carry-
ing the mcr-1 gene might be currently more prevalent 
among ESBL-producing isolates than among carbap-
enemase-producing isolates in human samples, which 
would explain why we did not identify this gene in our 
collection of carbapenemase-producing isolates.
Amikacin and fosfomycin were most effective against 
the colistin and carbapenem-resistant K. pneumoniae 
(susceptibility rates of 80% and 75%, respectively) and 
Table 1
Oligonucleotides used as primers in this study, France, 
January–December 2014 
Oligonucleotides Sequence (5’-3’) Reference
Kpn mgrB ext F TTA AGA AGG CCG TGC TAT CC [7]
Kpn mgrB ext R AAG GCG TTC ATT CTA CCA CC [7]
Kpn mgrB int F CGG TGG GTT TTA CTG ATA GTC This study
Kpn mgrB int R GAA CAT CCT GGT CGC ACA TT This study
Ent mgrB ext F CGG TTT ACT CTA TGA AAC AAG TGC This study
Ent mgrB ext R GCG AAG GAA GGA AAT CAC CT This study
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Table 2a
Characteristics of the colistin-resistant Klebsiella pneumoniae and Enterobacter spp. clinical isolates, France, January–
December 2014 (n = 43) 
Isolate Site of isolation Origin
MIC 
CSa mgrB genotype Carbapenemase
Associated 
beta-
lactamase
Co-resistancesb ST PFGE
1 ? Picardie 32 mgrB WT OXA-48 CTX-M-15 CIP GM SXT 11 A
2 Catheter Picardie 8 mgrB WT OXA-48 CTX-M-15 CIP GM SXT TIG 11 A
3 Rectal swab Picardie 4 mgrB WT OXA-48 CTX-M-15 CIP GM SXT TIG 11 A
4 Rectal swab Picardie 4 mgrB WT OXA-48 CTX-M-15 CIP GM SXT TIG 11 A
5 Rectal swab Picardie 64 mgrB WT OXA-48 CTX-M-15 CIP GM SXT TIG 11 A
6 Urine Picardie 32 mgrB WT OXA-48 CTX-M-15 CIP GM SXT TIG 11 A
7 Rectal swab Picardie 64 mgrB WT OXA-48 CTX-M-15 CIP GM SXT TIG 11 A
8 Wound Picardie 4 mgrB WT OXA-48 CTX-M-15 CIP GM SXT TIG 11 A
9 Respiratory Picardie 4 mgrB WT OXA-48 CTX-M-15 CIP GM SXT TIG 11 A
10 Rectal swab Picardie 4 mgrB WT OXA-48 CTX-M-15 CIP GM SXT TIG 11 A
11 Rectal swab Picardie 8 mgrB WT OXA-48 CTX-M-15 CIP GM SXT TIG 11 A
12 Rectal swab Picardie 64 mgrB WT OXA-48 CTX-M-15 CIP GM SXT TIG 11 A
13 Rectal swab Picardie 8 mgrB WT OXA-48 CTX-M-15 CIP GM SXT TIG 11 A
14 Rectal swab Picardie 4 mgrB WT OXA-48 CTX-M-15 CIP GM SXT TIG 11 A
15 Rectal swab Picardie 4 mgrB WT OXA-48 CTX-M-15 CIP GM SXT TIG 11 A
16 Rectal swab Nord-Pas-de-Calais 128
IS1R in promoter region 
(between nt −45 and −46) OXA-48 CTX-M-15 CIP GM SXT TIG 147 B
17 Rectal swab Ile-de-France 128 mgrB WT NDM CTX-M-15 CIP GM SXT TIG 147 C
18 Rectal swab PACA >128 ISKpn26-like in coding region (between nt +74 and +75) KPC - CIP AK SXT TIG 258 D
19 Rectal swab Rhône-Alpes 128 MgrB truncated (27 amino acids) KPC - CIP AK SXT TIG 258 E
20 Blood PACA 16 Full gene deletionc KPC - CIP AK SXT TIG 258 F
21 Rectal swab Lorraine 64 Single nucleotide deletion (nt 74) OXA-48 CTX-M-15 CIP GM 101 G
22 Rectal swab Ile-de-France 32 Single nucleotide deletion (nt 23) OXA-48 CTX-M-15 CIP GM 101 H
23 Rectal swab Ile-de-France 64 IS1R in promoter region (between nt −36 and −37) OXA-48 + NDM CTX-M-15 CIP GM 101 I
24 Urine PACA 64 IS1R in promoter region (between nt −45 and −46) OXA-48 CTX-M-15 CIP GM SXT TIG 101 J
25 Abcess Ile-de-France 32 MgrB M27K OXA-48 CTX-M-15 CIP GM 101 K
26 Urine Pays de la Loire 128 Duplication of 19 nucleotides OXA-48 CTX-M-15 CIP SXT FOS 101 L
27 Urine PACA 64 IS1R in coding region (between nt +21 and +22) OXA-48 CTX-M-15 CIP GM SXT TIG 307 M
28 Rectal swab PACA 64 mgrB WT OXA-48 CTX-M-15 CIP GM SXT TIG FOS 307 M
29 Rectal swab PACA 64 IS5-like in coding region (between nt +74 and +75) OXA-48 CTX-M-15 CIP GM SXT TIG 307 M
30 Urine PACA >128 Full gene deletionb OXA-48 - CIP GM AK SXT TIG FOS 611 N
31 Rectal swab Ile-de-France 32 ISKpn14-like in promoter region (between nt −45 and −46) OXA-48 - CIP GM SXT TIG 23 O
Isolates 1-35: Klebsiella pneumoniae; 36–42: Enterobacter cloacae; 43: Enterobacter asburiae.
AK: amikacin; CIP: ciprofloxacin; CS: colistin; FOS: fosfomycin; GM: gentamicin; MIC: minimum inhibitory concentration; NA: not applicable; 
nt: nucleotide; PACA: Provence-Alpes-Côte-d’Azur; PFGE: pulsed-field gel electrophoresis; ST: sequence type; SXT: trimethoprim-
sulfamethoxazole; TIG: tigecycline; WT: wildtype.
a MIC of colistin determined by broth microdilution method.
b Resistant or intermediate susceptibility to antibiotic.
c Full gene deletion: no PCR product was detected with external or internal primers.
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E. cloacae isolates (susceptibility rates of 87%). The 
rate of tigecycline non-susceptibility was high (70% for 
K. pneumoniae and 50% for Enterobacter spp.), prob-
ably because of a strong selective pressure by this 
last-line antibiotic.
Conclusion
This national survey on carbapenemase-producing iso-
lates recovered in 2014 discovered a high rate of colis-
tin resistance in K. pneumoniae and E. cloacae (6.2% 
and 7.7%, respectively) in France. These resistance 
rates remain much lower than those observed in other 
European countries such as Greece, Italy and Spain. 
No plasmid-encoded mcr-1 gene was identified here. 
Therefore it seems that it is still possible to control the 
spread of those multidrug-resistant isolates based on 
accurate identification of colistin resistance and isola-
tion of plasmid-encoded MCR-1 producers. Amikacin 
and fosfomycin remained the antibiotic agents most 
effective against those isolates which were resistant to 
polymyxins and produced a carbapenemase.
Acknowledgements
This work was supported by the University of Fribourg and 
partially funded by the Institut de Veille Sanitaire (InVS).
Conflict of interest
None declared.
Authors’ contributions
AJ, LP, and PN contributed to the design of the study. AJ per-
formed the experiments. AJ, LP, and PN analysed the data. AJ, 
LP, LD, and PN contributed to the writing of the manuscript.
References
1. Monaco M, Giani T, Raffone M, Arena F, Garcia-Fernandez 
A, Pollini S,  et al.  Colistin resistance superimposed to 
endemic carbapenem-resistant Klebsiella pneumoniae: a 
rapidly evolving problem in Italy, November 2013 to April 
2014. Euro Surveill. 2014;19(42). DOI: 10.2807/1560-7917.
ES2014.19.42.20939 PMID: 25358041
2. Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J,  et 
al.  Emergence of plasmid-mediated colistin resistance 
mechanism MCR-1 in animals and human beings in China: a 
microbiological and molecular biological study. Lancet Infect 
Dis. 2016;16(2):161-8. DOI: 10.1016/S1473-3099(15)00424-7 
PMID: 26603172
3. Clinical and Laboratory Standards Institute (CLSI). Methods for 
dilution of antimicrobial susceptibility tests for bacteria that 
grow aerobically. Approved standard, 9th ed. CLSI document 
M07-A10. Wayne: CLSI; 2015.
4. European Committee on Antimicrobial Susceptibility Testing 
(EUCAST). Breakpoints tables for interpretation of MICs and 
zone diameters, Version 5.0. Växjö: EUCAST. 2015.
5. Cannatelli A, Giani T, D’Andrea MM, Di Pilato V, Arena F, Conte 
V,  et al.  MgrB inactivation is a common mechanism of colistin 
Isolate Site of isolation Origin
MIC 
CSa mgrB genotype Carbapenemase
Associated 
beta-
lactamase
Co-resistancesb ST PFGE
32 Rectal swab PACA 32 IS102-like in coding region (between nt +36 and +37) OXA-48 CTX-M-15 CIP GM SXT TIG 20 P
33 Respiratory Ile-de-France 32 IS1R in promoter region (between nt −61 and −62) OXA-48 CTX-M-15 CIP SXT TIG FOS Q
34 Blood PACA >128 mgrB WT OXA-48 CTX-M-15 CIP SXT TIG 39 R
35 Rectal swab PACA 32 MgrB truncated (32 amino acids) OXA-48 - FOS 13 S
36 Rectal swab Nord-Pas-de-Calais 64 mgrB WT OXA-48 + VIM CTX-M-15 CIP GM SXT NA T
37 Stools Languedoc-Roussillon 64 mgrB WT OXA-48 CTX-M-15 GM AK NA U
38 Respiratory Ile-de-France 32 mgrB WT VIM - SXT TIG NA V
39 Rectal swab PACA >128 mgrB WT OXA-48 - CIP GM SXT TIG NA W
40 Rectal swab Ile-de-France 16 mgrB WT OXA-48 - FOS NA X
41 Rectal swab PACA >128 mgrB WT IMP CTX-M-2 No NA Y
42 Respiratory Rhône-Alpes >128 mgrB WT OXA-48 - TIG NA Z
43 Urine Nord-Pas-de-Calais >128 mgrB WT VIM-1 - CIP TIG NA α
Table 2b
Characteristics of the colistin-resistant Klebsiella pneumoniae and Enterobacter spp. clinical isolates, France, January–
December 2014 (n = 43) 
Isolates 1-35: Klebsiella pneumoniae; 36–42: Enterobacter cloacae; 43: Enterobacter asburiae.
AK: amikacin; CIP: ciprofloxacin; CS: colistin; FOS: fosfomycin; GM: gentamicin; MIC: minimum inhibitory concentration; NA: not applicable; 
nt: nucleotide; PACA: Provence-Alpes-Côte-d’Azur; PFGE: pulsed-field gel electrophoresis; ST: sequence type; SXT: trimethoprim-
sulfamethoxazole; TIG: tigecycline; WT: wildtype.
a MIC of colistin determined by broth microdilution method.
b Resistant or intermediate susceptibility to antibiotic.
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